Preliminary results have shown that TVSI delivery is well-tolerated, and dose escalation did not lead to an increasing trend in reported adverse events.
1
—
—
Preliminary results have shown that TVSI delivery is well-tolerated, and dose escalation did not lead to an increasing trend in reported adverse events.